EZZ凭基因科技入选创新研发案例锚定全生命周期健康

Core Insights - EZZ Life Science Holdings Limited has been awarded the "Outstanding R&D Innovation Enterprise" in the 2025 Sunshine Case Honor Roll, highlighting its leadership in gene technology and its effective market transformation capabilities [1] - The company is positioned as a benchmark for the precision transformation of the health industry, emphasizing its deep accumulation and innovative strength in the field of life cycle health management [1] Group 1: Gene Research and Market Strategy - EZZ is transitioning from a broad health approach to a precision health model, focusing on gene-centered life sciences to address fundamental health management needs [2] - The company has established a global top-tier research network in collaboration with institutions like the New Zealand Gene Research Center and the University of Sydney, creating a comprehensive R&D system from basic research to product implementation [2][4] - EZZ's growth capsule 3.0 targets the critical growth phase of adolescents, featuring a formula that enhances nutrient absorption and includes a combination of beneficial ingredients for comprehensive nutritional support [3] Group 2: Local Adaptation and Long-term Health Strategy - Under the "Healthy China 2030" initiative, EZZ integrates global research resources with local market needs, marking a significant step in the scientific validation of its growth series products [4] - The company adapts its products to meet specific dietary habits and health issues prevalent in China, such as controlling sugar content and developing easy-to-consume formulations for children [4] - EZZ aims to fill market gaps with targeted health solutions, such as specialized digestive health products for common dietary issues in Chinese families [4] Group 3: Future Innovations and Industry Positioning - EZZ plans to focus on three core technologies in the next one to two years: enhancing nutrient release and bioavailability in cell health, improving probiotic survival rates, and developing layered encapsulation techniques for better nutrient absorption [6] - The recognition of EZZ in the Sunshine Case reflects its strong R&D capabilities and market performance, aligning with the health industry's trends towards precision, scientific, and localized approaches [6] - As gene technology continues to evolve, EZZ is committed to providing high-quality, precise health solutions for various demographics, contributing to the high-quality development of the health industry [6]